Bupropion

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 38 USDMF, 11 EU WC, 8 KDMF, 33 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

30 Drugs in Development

30 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

263 FDF Dossiers, 133 FDA Orange Book, 85 Europe, 12 Canada, 2 Australia, 13 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 14 DKSH, 7 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Capital Farma, 1 Pramukh Pharmachem, 1 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 4 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 35 BASF, 2 Clariant, 16 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 15 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 39 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 21 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

100 Fillers, Diluents & Binders, 82 Coating Systems & Additives, 51 Controlled & Modified Release, 40 Solubilizers, 38 Direct Compression, 30 Lubricants & Glidants, 30 Film Formers & Plasticizers, 30 Granulation, 29 Thickeners and Stabilizers, 28 Taste Masking, 22 Parenteral, 21 Topical, 19 Disintegrants & Superdisintegrants, 18 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 11 Emulsifying Agents, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

92 NEWS #PharmaBuzz

92 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 62 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

11 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

23 US Patents, 30 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 USP, 16 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Teva agrees with Axsome to keep generic off market until 2038

11 Feb 2025

// FIERCE PHARMA

Axsome Advances Alzheimer's Drug Despite Mixed Trial Data

31 Dec 2024

// BIOSPACE

Enforcement Report - Week of December 13, 2023

13 Dec 2023

// FDA

Enforcement Report - Week of October 25, 2023

25 Oct 2023

// FDA

FDA Confirms Paragraph IV Patent Litigation for Dextromethorphan Hydrobromide and Bupropion Hydrochloride Extended-release Tablet

23 Feb 2023

// FDA

Enforcement Report - Week of February 22, 2023

22 Feb 2023

// FDA

Bupropion

Bupropion

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers

38 USDMF

11 EU WC

8 KDMF

33 NDC API

34 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

30 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

263 FDF Dossiers

133 FDA Orange Book

85 Europe

12 Canada

2 Australia

13 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG

TABLET, EXTENDED RELEASE;ORAL - 100MG

TABLET, EXTENDED RELEASE;ORAL - 150MG

TABLET, EXTENDED RELEASE;ORAL - 200MG

TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 150MG

TABLET, EXTENDED RELEASE;ORAL - 300MG

TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

1 Minakem

7 Evonik

2 Rochem International Inc

20 SPI Pharma

2 Seqens

14 DKSH

7 Faran Shimi Pharmaceutical

3 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

5 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Capital Farma

1 Pramukh Pharmachem

1 ACG Worldwide

6 Actylis

1 Aeon Procare

4 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

35 BASF

2 Clariant

16 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

3 Finar

12 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

15 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

39 Kerry

5 Kima Chemical

6 Lonza Capsugel

21 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

4 Novo Excipients

3 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons